As of 2025-06-17, the Fair Value of Nu-Med Plus Inc (NUMD) is -0.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.05 USD, the upside of Nu-Med Plus Inc is -128.98%.
With the market price of 0.05 USD and our fair value calculation, Nu-Med Plus Inc (NUMD) is not a good investment. Investing in NUMD stocks now will result in a potential loss of 128.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.01 | -0.83 | -0.13 | -0.13 | -0.07 | -0.63 |
| YoY growth | -93.76% | 58.68% | 84.32% | 3.56% | 45.55% | 19.67% |
| Market Cap (mil) | 4.51 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | 19.67% |
| TTM earnings | -0.07 |